$ISPC·8-K

iSpecimen Inc. · May 29, 5:13 PM ET

Compare

iSpecimen Inc. 8-K

Research Summary

AI-generated summary

Updated

iSpecimen Inc. Reports 2025 Annual Meeting Vote Results

What Happened
iSpecimen Inc. (ISPC) filed an 8-K on May 29, 2026 reporting the results of its reconvened 2025 Annual Meeting of Stockholders. Of 8,478,579 shares outstanding and eligible to vote (record date Nov 3, 2025), a quorum of 2,979,059 shares (≈35.14%) was present or represented by proxy. The meeting elected one Class I director, ratified the independent auditor for 2025, and approved the company’s 2025 Stock Incentive Plan.

Key Details

  • Director elected: Arphing (Tommy) Lee was elected Class I director. Vote: For 562,361; Withheld 150,431; Broker non-vote 2,266,267.
  • Auditor ratified: Bush & Associates CPA LLC was ratified as the independent registered public accounting firm for year ending Dec 31, 2025. Vote: For 2,424,420; Against 155,256; Abstain 399,383.
  • Stock plan approved: iSpecimen Inc. 2025 Stock Incentive Plan approved. Vote: For 461,073; Against 186,740; Abstain 64,979; Broker non-vote 2,266,267.
  • Voting context: Large broker non-vote totals (2,266,267 shares) reduced the number of shares voting on certain proposals.

Why It Matters
These outcomes confirm the company’s board composition and give the company authority to grant equity under the approved 2025 Stock Incentive Plan, which can be used for employee and director compensation and may lead to future share dilution. Ratification of the auditor preserves the company’s audited reporting process for 2025. Investors should note the low shareholder turnout (~35%) and substantial broker non-votes, which affected vote totals on the director election and stock plan.

Loading document...